CD8A and cancer: For regimens of adoptive cell transfer, widely explored in the field of cancer and Epstein-Barr virus–associated malignancies, it is known that CD8+ T-cell differentiation widely affects the anti-tumoral response: although effector memory cells have fully functional differentiation, the diminished proliferative capacity severely compromises the success of the adoptive transfer because the effect is transient.